Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07HNM
|
||||
Former ID |
DNC011864
|
||||
Drug Name |
1,3-Diallyl-3,7-dihydro-purine-2,6-dione
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [533429] | ||
Structure |
Download2D MOL |
||||
Formula |
C11H12N4O2
|
||||
Canonical SMILES |
C=CCN1C2=C(C(=O)N(C1=O)CC=C)NC=N2
|
||||
InChI |
1S/C11H12N4O2/c1-3-5-14-9-8(12-7-13-9)10(16)15(6-4-2)11(14)17/h3-4,7H,1-2,5-6H2,(H,12,13)
|
||||
InChIKey |
NUZFZZOVBJUJQN-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A2b receptor | Target Info | Inhibitor | [533429] | |
Adenosine A1 receptor | Target Info | Inhibitor | [533429] | ||
Adenosine A2a receptor | Target Info | Inhibitor | [533429] | ||
KEGG Pathway | Rap1 signaling pathway | ||||
Calcium signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Vascular smooth muscle contraction | |||||
Alcoholismhsa04022:cGMP-PKG signaling pathway | |||||
cAMP signaling pathway | |||||
Sphingolipid signaling pathway | |||||
Morphine addictionhsa04015:Rap1 signaling pathway | |||||
Parkinson's disease | |||||
Alcoholism | |||||
Pathway Interaction Database | C-MYB transcription factor networkhif2pathway:HIF-2-alpha transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.